Search research articles
Contact Us
Filters
Showing results (1-10 of 70) with videos related to
Page
of 7
Sort By:
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 1, 1976
Biochemical markers in cancer of the breast
D C Tormey, T P Waalkes
Seminars in Oncology
|
December 1, 1978
Biologic markers and breast cancer
T P Waalkes, D C Tormey
The Journal of Laboratory and Clinical Medicine
|
May 1, 1970
he determination of pentamidine (4,4'-diamidinophenoxypentane) in plasma, urine, and tissues
T P Waalkes, V T DeVita
Geriatrics
|
January 1, 1983
Meeting the challenge of cancer control: a case in point
W P Vaughan, T P Waalkes
National Cancer Institute Monograph
|
October 1, 1976
Pharmacologic aspects of pentamidine
T P Waalkes, D R Makulu
Cancer
|
September 1, 1978
Clinical correlation between CEA and breast cancer
D C Tormey, T P Waalkes
European Journal of Cancer
|
January 1, 1980
Biological markers as prognostic and clinical evaluation tools
D C Tormey, T P Waalkes
Journal of the National Cancer Institute
|
February 1, 1975
Interaction between aromatic diamidines and nucleic acids: possible implications for chemotherapy
D R Makulu, T P Waalkes
Journal of the National Cancer Institute
|
February 1, 1975
Serum levels of N2, N2-dimethylguanosine and pseudouridine as determined by radioimmunoassay for patients with malignancy
L Levine, T P Waalkes, L Stolbach
Clinical Pharmacology and Therapeutics
|
July 1, 1970
Pentamidine: clinical pharmacologic correlations in man and mice
T P Waalkes, C Denham, V T DeVita
Page
of 7
Search research articles
Search
Showing results (1-10 of 70) with videos related to
Sort By:
Page
of 7
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 1, 1976
Biochemical markers in cancer of the breast
D C Tormey, T P Waalkes
Seminars in Oncology
|
December 1, 1978
Biologic markers and breast cancer
T P Waalkes, D C Tormey
The Journal of Laboratory and Clinical Medicine
|
May 1, 1970
he determination of pentamidine (4,4'-diamidinophenoxypentane) in plasma, urine, and tissues
T P Waalkes, V T DeVita
Geriatrics
|
January 1, 1983
Meeting the challenge of cancer control: a case in point
W P Vaughan, T P Waalkes
National Cancer Institute Monograph
|
October 1, 1976
Pharmacologic aspects of pentamidine
T P Waalkes, D R Makulu
Cancer
|
September 1, 1978
Clinical correlation between CEA and breast cancer
D C Tormey, T P Waalkes
European Journal of Cancer
|
January 1, 1980
Biological markers as prognostic and clinical evaluation tools
D C Tormey, T P Waalkes
Journal of the National Cancer Institute
|
February 1, 1975
Interaction between aromatic diamidines and nucleic acids: possible implications for chemotherapy
D R Makulu, T P Waalkes
Journal of the National Cancer Institute
|
February 1, 1975
Serum levels of N2, N2-dimethylguanosine and pseudouridine as determined by radioimmunoassay for patients with malignancy
L Levine, T P Waalkes, L Stolbach
Clinical Pharmacology and Therapeutics
|
July 1, 1970
Pentamidine: clinical pharmacologic correlations in man and mice
T P Waalkes, C Denham, V T DeVita
Page
of 7